GENC

Gencor Is Cheap – For Good Reason

moreView todays social media effects on GENCView the latest stocks trending across Twitter. Click to view dashboardSee who Gencor is hiring next, click here to view […]

Genmab to Present at the 31st Annual J.P. Morgan Healthcare Conference

[at noodls] – Media Release Copenhagen, Denmark; January 3, 2013 -Genmab A/S (OMX: GEN) announced today its CEO, Jan van de Winkel, Ph.D., will present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco … moreView todays social media effects on GENCView the latest stocks trending across Twitter. Click to view dashboardSee who Gencor is hiring next, click […]

Genmab Unveils A New Antibody Technology Platform: HexaBody

[at noodls] – Company Announcement HexaBody platform is a novel technology platform to potently enhance antibody therapeutics Multiple new business opportunities created Additional details on technology platform to … moreView todays social media effects on GENCView the latest stocks trending across Twitter. Click to view dashboardSee who Gencor is hiring next, click here to view […]

Genmab Reduces Fair Value of Minnesota Manufacturing Facility to Zero, Moves Sale into 2013 and Updates 2012 Guidance

[at noodls] – Company Announcement Fair value of the manufacturing facility reduced to zero Non-cash impairment charge of DKK 331 million (USD 58 million) Sale now projected in Q1 2013, aggressive sales process proceeding … moreView todays social media effects on GENCView the latest stocks trending across Twitter. Click to view dashboardSee who Gencor is hiring next, click here to […]

Genmab Reaches Milestone in DuoBody Platform Collaboration with Janssen

[at noodls] – Company Announcement Genmab reaches key milestone in DuoBody® platform collaboration with Janssen $2 million milestone payment to Genmab Copenhagen, Denmark; December 11, 2012 -Genmab A/S (OMX: GEN) announced … moreView todays social media effects on GENCView the latest stocks trending across Twitter. Click to view dashboardSee who Gencor is hiring next, click here to view […]

New Preliminary Efficacy Data for Daratumumab Presented at ASH

[at noodls] – Company Announcement Preliminary safety and efficacy data from final patients in part 1 of study continue to be encouraging Data presented in oral presentation today at the ASH Annual Meeting Part 2 of … moreView todays social media effects on GENCView the latest stocks trending across Twitter. Click to view dashboardSee who Gencor is hiring next, click […]

Genmab’s Financial Calendar for 2013

[at noodls] – Company Announcement Copenhagen, Denmark; December 6, 2012 -Genmab A/S (OMX: GEN) announces its financial calendar for 2013 as follows: EVENT DATE Publication of the Annual Report for 2012 Thursday, March … moreView todays social media effects on GENCView the latest stocks trending across Twitter. Click to view dashboardSee who Gencor is hiring next, click here to view […]

Grant of Warrants to Board Members, Management and Employees in Genmab

[at noodls] – Company Announcement Copenhagen, Denmark; December 5, 2012-Genmab A/S (OMX: GEN) announced today that at a board meeting the board decided to issue 325,000 warrants to members of the board of directors, … moreView todays social media effects on GENCView the latest stocks trending across Twitter. Click to view dashboardSee who Gencor is hiring next, click here to […]

Report Pursuant to Section 28a of the Danish Securities Trading Act

[at noodls] – Company Announcement Copenhagen, Denmark; December 5, 2012 -Pursuant to Section 28a of the Danish Securities Trading Act, Genmab A/S (OMX: GEN) shall make public information on transactions by managerial … moreView todays social media effects on GENCView the latest stocks trending across Twitter. Click to view dashboardSee who Gencor is hiring next, click here to view […]